Extracorporeal Shock Wave Therapy in the Treatment of Primary Dysmenorrhea
Dysmenorrhea Primary, Pain, Menstrual
About this trial
This is an interventional treatment trial for Dysmenorrhea Primary focused on measuring primary dysmenorrhea, extracorporeal shock wave therapy, traditional Chinese medicine
Eligibility Criteria
Inclusion Criteria:
- diagnosed with PD ;
- women aged from 18 to 30 years;
- painful and relatively regular menstruation (duration of menstrual cycle 21 to 35 days) in recent three cycles with maximum pain intensity over 40 mm according to 10 cm visual analog scale (VAS), with primary dysmenorrhea pain features;
- willing to or already taking part in clinical trials;
- able to sign an informed consent
Exclusion Criteria:
- known lactose intolerance or chronic disease (including epilepsy, gastrointestinal, cardio-vascular or renal diseases);
- taking oral contraceptives, or regularly taking mineral or vitamin supplements in the past 3 months;
- women in pregnant women, or those with plans to get pregnant during any period of the trial;
- have experience of acupuncture
Sites / Locations
- Jian Yang
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Placebo Comparator
ESWT during PD
ESWT before PD
hot compress paste
For women with primary dysmenorrhea, they have new devise Extracorporeal Shock Wave Therapy to treat. The dose is 15 hertz, 1.8-2.2bar and total 5000 frequencies approximately. The time is menstrual cycle first one and third day, and the therapy divide into two times.
For women with primary dysmenorrhea, they have new devise Extracorporeal Shock Wave Therapy to treat. The dose is 15 hertz, 1.8-2.2 bar and total 5000 frequencies approximately. The time start from the 5th and 7th day before the estimated first day of menstrual cycle and all therapy time consuming need 15 minutes.
In hot compress paste group , the women with primary dysmenorrhea stick the hot compress paste on their belly autonomously.